Pharmaceutical, Diagnostic Companies Launch Research Into Zika Virus Vaccine, Test
Associated Press: Drugmaker Sanofi Pasteur launches effort for Zika vaccine
“Drugmaker Sanofi Pasteur announced Tuesday it is launching an effort to research and develop a vaccine to prevent the Zika virus, after the World Health Organization declared a global emergency over its explosive spread across the Americas…” (2/2).
Bloomberg Business: Sanofi to Work on Zika Vaccine as Health Emergency Declared
“…The French drugmaker plans to harness its work against dengue fever to attack Zika, a virus from the same family, Sanofi said in a statement on Tuesday…” (Fourcade, 2/2).
Financial Times: Sanofi leads hunt for Zika vaccine
“…The company said its R&D and industrial infrastructure could be ‘rapidly leveraged’ to help understand the spread of Zika and potentially speed identification of a vaccine candidate for development…” (Ward, 2/2).
Reuters: Sanofi launches hunt for Zika vaccine as disease fears grow
“…So far, the only groups with firm plans to develop a Zika vaccine are small biotech companies and academic institutions, although GlaxoSmithKline has said it is concluding feasibility studies to evaluate if its vaccine technology is suitable…” (Vidalon/Hirschler, 2/2).
Washington Post: A Md. biotech firm claims it can track Zika virus by testing mosquitoes
“…After a 21-day sprint, GenArraytion claims to have come up with a molecular test that can spot the [Zika] virus in mosquitoes before it infects humans. The goal is to give health agencies a better way to map the virus…” (Gregg, 2/1).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.